THROMBOSIS RISK FACTOR ASSESSMENT

Similar documents
INDICATIONS FOR THROMBO-PROPHYLAXIS AND WHEN TO STOP ANTICOAGULATION BEFORE ELECTIVE SURGERY

Low-Molecular-Weight Heparin

NoCVA Hospital Engagement Network SSI/VTE Safe Surgery Collaborative. December 13, 2012

Tarkten A Pharr, MD, FACS 04/26/2018. VTE Prevention Strategies: Is a One Size Fits all Approach Correct?

Venous Thromboembolism Prophylaxis

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?

Anticoagulation for prevention of venous thromboembolism

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Mabel Labrada, MD Miami VA Medical Center

Predicting Venous Thromboembolic Complications following Neurosurgical Procedures

Pharmacy Prior Authorization

Getting Started Kit VENOUS THROMBOEMBOLISM PREVENTION. Section 2: Evidence-Based Appropriate VTE Prophylaxis

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies

NICE Guidance: Venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital 1

Approach to Thrombosis

1. SCOPE of GUIDELINE:

Venous thrombosis is common and often occurs spontaneously, but it also frequently accompanies medical and surgical conditions, both in the community

Venous Thromboembolism. Prevention

Alan Banks, DPM Tucker, GA

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge

Perioperative VTE Prophylaxis

Low Molecular Weight Heparin for Prevention and Treatment of Venous Thromboembolic Disorders

Hemostasis. PHYSIOLOGICAL BLOOD CLOTTING IN RESPONSE TO INJURY OR LEAK no disclosures

Are there still any valid indications for thrombophilia screening in DVT?

Venous thromboembolism - reducing the risk

These are guidelines only and can be deviated from if it is thought to be in the patient s best interest.

Venous thromboembolism: reducing the risk

Dr. Riaz JanMohamed Consultant Haematologist The Hillingdon Hospital Foundation Trust

Misunderstandings of Venous thromboembolism prophylaxis

ADULT TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) TELEMETRY BED TRANSFER ORDERS 1 of 4

Slide 1. Slide 2. Slide 3. Outline of This Presentation

Perioperative VTE prophylaxis (ACCP 9 th edition Guidelines) Gamal Marey SUNY Downstate Medical Center 10/16/2014

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

CHAPTER 2 VENOUS THROMBOEMBOLISM

ADULT CARDIAC SURGERY TELEMETRY BED TRANSFER ORDERS 1 of 4

Prevention of Venous Thromboembolism

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT

Deep Vein Thrombosis and Pulmonary Embolism: Patient Information

DENOMINATOR: All surgical patients aged 18 years and older undergoing procedures for which VTE prophylaxis is indicated in all patients

The Johns Hopkins Hospital Patient Information. How Do I Prevent Blood Clots? Venous Thromboembolism (VTE) Deep Vein Thrombosis (DVT)

Venous Thromboembolism (VTE) Prevention

Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital

The Royal College of Emergency Medicine. VTE Risk in Lower Limb Immobilisation in Plaster Cast 2015/2016

A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Method

t. Recommendations for periprocedural anticoagulation are available lhrough the American College of Chest Physicians Clinical Practice Guidelines.

Venothromboembolism prophylaxis: Trauma and Orthopaedics Clinical guideline, V2

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales

Prevention and management of venous thromboembolism M. AAPRO

*Corresponding Author:

OBSTETRIC ADMISSION ORDERS 1 of 4

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

Guidelines for Prevention of Venous Thromboembolism in Adults

10/8/2012. Disclosures. Making Sense of AT9: Review of the 2012 ACCP Antithrombotic Guidelines. Goals and Objectives. Outline

Deep Vein Thrombosis and Pulmonary Embolism in the Perioperative Patient

Thrombophilia. Diagnosis and Management. Kevin P. Hubbard, DO, FACOI

Mutidisciplinary cooperation on VTE prevention and managment

Updates in Diagnosis & Management of VTE

Thrombophilia. Stephan Moll, MD Medicine, Heme-Coag UNC Chapel Hill, NC. GASCO Atlanta Sept 8 th, Disclosures. Conflicts of interest: NONE

Elements for a Public Summary Overview of disease epidemiology

Utilization of DVT Prophylaxis in non ICU Hospitalized Patients

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593

Deep vein thrombosis (DVT) and pulmonary embolism (PE) advice for ophthalmic surgery patients

Duration of anticoagulation

Primary VTE Prophylaxis. Ponlapat Rojnuckarin, MD PhD Chulalongkorn University Bangkok, Thailand

DOAC for VTE. Direct Oral Anticoagulants Clint Shedd DNP, FNP-BC Emory University

How long to continue anticoagulation after DVT?

Suspected Deep Vein Thrombosis (DVT) Assessment

Guideline Quick View: Venous Thromboembolism

GENERAL SURGICAL ADULT POST-OPERATIVE ORDERS 1 of 4

DVT - initial management NSCCG

Medical Patients: A Population at Risk

Prophylaxis for Hospitalized and Non-Hospitalized Medical Patients

Sindrome da anticorpi antifosfolipidi: clinica e terapia. Vittorio Pengo Clinical Cardiology, Padova, Italy

Measure #23 (NQF 0239): Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients)

Updates in Medical Management of Pulmonary Embolism and Deep Vein Thrombosis. By: Justin Youtsey, Elliott Reiff, William Montgomery, Grant Finlan

THROMBOPHILIA TESTING: PROS AND CONS SHANNON CARPENTER, MD MS CHILDREN S MERCY HOSPITAL KANSAS CITY, MO

Dr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton

Symptomatic Venous Thromboembolism after Total Hip/Knee Replacement: A Population-based Taiwan Study

Sinus and Cerebral Vein Thrombosis

Donald M. Arnold, MD; Susan R. Kahn, MD, MSc; and Ian Shrier, MD, PhD

General. Recommendations. Guideline Title. Bibliographic Source(s) Guideline Status. Major Recommendations

ASHP Therapeutic Position Statement on the Role of Pharmacotherapy in Preventing Venous Thromboembolism in Hospitalized Patients

GUIDELINE FOR THROMBOPROPHYLAXIS IN ADULT (18 YEARS AND OLDER) IN GENERAL MEDICAL PATIENTS AND INPATIENTS UNDERGOING SURGERY

New Oral Anticoagulant Drugs in the Prevention of DVT

THROMBOPROPHYLAXIS: NON-ORTHOPEDIC SURGERY

Thrombophilia: To test or not to test

Hematologic Disorders. Assistant professor of anesthesia

TRANSPARENCY COMMITTEE OPINION. 18 April 2007

UC SF. Division of General Internal Medicine UNIVERSITY OF CALIFORNIA SAN FRANCISCO, DIVISION OF HOSPITAL MEDICINE

Cover Page. The handle holds various files of this Leiden University dissertation.

Update on the risk of DVT during air travel - does the economy class syndrome really exist?

Drug Class Review Newer Oral Anticoagulant Drugs

Transcription:

Name: Procedure: Doctor: Date: THROMBOSIS RISK FACTOR ASSESSMENT CHOOSE ALL THAT APPLY EACH RISK FACTOR REPRESENTS 1 POINT Age 41 60 years Minor Surgery Planned History of Prior Major Surgery (< 1 month) Varicose Veins History of Inflammatory Bowel Disease Swollen Legs (current) Obesity (BMI >25) Acute Myocardial Infarction Congestive Heart Failure (< 1 month) Sepsis (1< month) Serious Lung Disease Including Pneumonia (< 1 month) Abnormal Pulmonary Function (COPD) Medical Patient Currently at Bed Rest Other Risk Factors: FOR WOMEN ONLY EACH REPRESENTS 1 POINT Oral Contraceptives or Hormone Replacement Therapy Pregnancy or Postpartum (< 1 month) History of Unexplained Stillborn Infant, Recurrent Spontaneous Abortion (>3) Premature birth with Toxemia or Growth-Restricted Infant. EACH RISK FACTOR REPRESENTS 2 POINTS Age 60 74 Years Arthroscopic Surgery Malignancy (present or previous) Major Surgery (>45 minutes) Laparoscopic Surgery (>45 minutes) Patient Confined to Bed (>72 hours) Immobilizing Plaster Cast (<1 month) Central Venous Access EACH RISK FACTOR REPRESENTS 3 POINTS Age over 75 Years History of DVT/PE Family History of Thrombosis Positive Factor V Leiden Elevated Serum Homocysteine Positive Prothrombin 20210A Elevated Anticardiolipin Antibodies Positive Lupus Anticoagulant Heparin-induced Thrombocytopenia (HIT) Other Congenital or Acquired Thrombophilia If yes: most frequently missed risk factor EACH RISK FACTOR REPRESENTS 5 POINTS Elective Major Lower Extremity Orthroplasty Hip, Pelvis or Leg Fracture (<1 month) Stroke (< 1 month) Multiple Trauma (< month) Acute Spinal Cord Injury (paralysis) (< 1 month) TOTAL RISK FACTOR SCORE VTE PROPHYLAXIS No VTE Prophylaxis Indicated. Risk of Bleeding Outweighs VTE Prophylaxis Mechanical Prophylaxis. Pre Operative Heparin 5,000U. Post Operative Prophylaxis Extended LMWH. Physician Signature: Date: Public Files: Surgery Documents 2/2014

Name: Procedure: Doctor: Date: THROMBOSIS RISK FACTOR ASSESSMENT CHOOSE ALL THAT APPLY EACH RISK FACTOR REPRESENTS 1 POINT Age 41 60 years Minor Surgery Planned History of Prior Major Surgery (< 1 month) Varicose Veins History of Inflammatory Bowel Disease Swollen Legs (current) Obesity (BMI >25) Acute Myocardial Infarction Congestive Heart Failure (< 1 month) Sepsis (1< month) Serious Lung Disease Including Pneumonia (< 1 month) Abnormal Pulmonary Function (COPD) Medical Patient Currently at Bed Rest Other Risk Factors: FOR WOMEN ONLY EACH REPRESENTS 1 POINT Oral Contraceptives or Hormone Replacement Therapy Pregnancy or Postpartum (< 1 month) History of Unexplained Stillborn Infant, Recurrent Spontaneous Abortion (>3) Premature birth with Toxemia or Growth-Restricted Infant. EACH RISK FACTOR REPRESENTS 2 POINTS Age 60 74 Years Arthroscopic Surgery Malignancy (present or previous) Major Surgery (>45 minutes) Laparoscopic Surgery (>45 minutes) Patient Confined to Bed (>72 hours) Immobilizing Plaster Cast (<1 month) Central Venous Access EACH RISK FACTOR REPRESENTS 3 POINTS Age over 75 Years History of DVT/PE Family History of Thrombosis Positive Factor V Leiden Elevated Serum Homocysteine Positive Prothrombin 20210A Elevated Anticardiolipin Antibodies Positive Lupus Anticoagulant Heparin-induced Thrombocytopenia (HIT) Other Congenital or Acquired Thrombophilia If yes: most frequently missed risk factor EACH RISK FACTOR REPRESENTS 5 POINTS Elective Major Lower Extremity Orthroplasty Hip, Pelvis or Leg Fracture (<1 month) Stroke (< 1 month) Multiple Trauma (< month) Acute Spinal Cord Injury (paralysis) (< 1 month) TOTAL RISK FACTOR SCORE

VTE RISK and SUGGESTED PROPHYLAXIS FOR SURGICAL PATIENTS Total Risk Factor Score Incidence of DVT 0-1 < 10% 0% Low Risk 30 day Proven DVT Incidence Risk Level Prophylaxis Regimen No specific measures; early ambulation 2 10 20% 0.7% Moderate Risk 3-4 20-40% 0.97% High Risk 5 or more 40 80% 1-5% mortality 1.94% Highest Risk IPC, LDUH (5000U BID), LWMH(<3400U) IPC, LDUH (5000U TID), or LMWH (>3400U) or FXa l Pharmacological: LDUH, LMWH (>3400U), Warfarin, or FXa l alone or in combination with IPC BMI 19 20 21 22 23 24 25 26 27 28 29 30 35 40 Height Weight (lbs.) 4 10 91 96 100 105 110 115 119 124 129 134 138 143 167 191 4 11 94 99 104 109 114 119 124 128 133 138 143 148 173 198 5 0 97 102 107 112 118 123 128 133 138 143 148 153 179 204 5 1 100 106 111 116 122 127 132 137 143 148 153 158 185 211 5 2 104 109 115 120 126 131 136 142 147 153 158 164 191 218 5 3 107 113 118 124 130 135 141 146 152 158 163 169 197 225 5 4 110 116 122 128 134 140 145 151 157 163 169 174 204 232 5 5 114 120 126 132 138 144 150 156 162 168 174 180 210 240 5 6 118 124 130 136 142 148 155 161 167 173 179 186 216 247 5 7 121 127 134 140 146 153 159 166 172 178 185 191 223 255 5 8 125 131 138 144 151 158 164 171 177 184 190 197 230 262 5 9 128 135 142 149 155 162 169 176 182 189 196 203 236 270 5 10 132 139 146 153 160 167 174 181 188 195 202 207 243 278 5 11 136 143 150 157 165 172 179 186 193 200 208 215 250 286 6 0 140 147 154 162 169 177 184 191 199 206 213 221 258 294 6 1 144 151 159 166 174 182 189 197 204 212 219 227 265 302 6 2 148 155 163 171 179 186 194 202 210 218 225 233 272 311 6 3 152 160 168 176 184 192 200 208 216 224 232 240 279 319 6 4 156 164 172 180 189 197 205 213 221 230 238 246 287 328 Public Files: Surgery Documents 2/2014